This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
I welcome the opportunity to respond to Mr Helmeczi's comments on the PMI program and, more specifically, his concern that this AMA initiative fails to recognize the contributions of pharmacists to improving the flow of drug information to patients.When AMA initiated the PMI program, it did so in full realization of the many excellent existing sources of drug information, including those developed and implemented by pharmacy. The program draws on the United States Pharmacopeia dispensing information data base in the development of PMIs. At no time did the association intend not to recognize the valuable contributions that pharmacists make or to imply, as Mr Helmeczi suggests, that physicians should be the sole source of drug information for patients. We do maintain, however, that, because of their knowledge of the individual patient's health problems and their responsibilities to prescribe drugs, physicians are the most important source of drug
Sammons JH. American Medical Association Patient Medication Instruction (PMI) Program-Reply. JAMA. 1983;249(17):2327. doi:10.1001/jama.1983.03330410025012